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Summary
Background: The developmental history of the chondrocyte results in a cell whose biosynthetic activities are optimized to maintain the con-
centration and organization of a mechanically functional cartilaginous extracellular matrix. While useful for cartilage tissue engineering studies,
the limited supply of healthy autologous chondrocytes may preclude their clinical use. Consequently, multipotential mesenchymal stem cells
(MSCs) have been proposed as an alternative cell source.
Objective: While MSCs undergo chondrogenesis, few studies have assessed the mechanical integrity of their forming matrix. Furthermore,
efﬁciency of matrix formation must be determined in comparison to healthy chondrocytes from the same donor. Given the scarcity of healthy
human tissue, this study determined the feasibility of isolating bovine chondrocytes and MSCs, and examined their long-term maturation in
three-dimensional agarose culture.
Experimental design: Bovine MSCs were seeded in agarose and induced to undergo chondrogenesis. Mechanical and biochemical properties
of MSC-laden constructs were monitored over a 10-week period and compared to those of chondrocytes derived from the same group of ani-
mals maintained similarly.
Results: Our results show that while chondrogenesis does occur in MSC-laden hydrogels, the amount of the forming matrix and measures of
its mechanical properties are lower than that produced by chondrocytes under the same conditions. Furthermore, some important properties,
particularly glycosaminoglycan content and equilibrium modulus, plateau with time in MSC-laden constructs, suggesting that diminished ca-
pacity is not the result of delayed differentiation.
Conclusions: These ﬁndings suggest that while MSCs do generate constructs with substantial cartilaginous properties, further optimization
must be done to achieve levels similar to those produced by chondrocytes.
Published by Elsevier Ltd on behalf of OsteoArthritis Research Society International.
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SocietyIntroduction
The high prevalence of osteoarthritis1,2 and the poor intrin-
sic healing capacity of articular cartilage engender a de-
mand for cell-based strategies for cartilage repair.
Consequently, numerous studies have explored the produc-
tion of cartilage equivalents via the combination of scaffolds
or hydrogels with differentiated chondrocytes3e10. While the
use of chondrocytes has been important in delineating the
path by which tissue engineering may produce replacement
tissues, it is likely that the use of only fully differentiated
cells to populate engineered constructs is an untenable
goal. This is due to the limited supply of such cells, their
de-differentiation with extensive monolayer expansion11,12.
Tissue harvest, even from non-weight bearing sites, may
further complicate a damaged joint, and harvested cells
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Received 21 April 2005; revision accepted 5 September 2005.17may themselves be inferior in terms of matrix production
due to age and/or disease processes13,14.
One opportunity for overcoming such concerns is the use
of multipotent, adult mesenchymal stem cells (MSCs)15,16.
These cells are easily obtained from bone marrow aspirates
and retain a multi-lineage differentiation potential; that is,
theymay differentiate along a number of different mesenchy-
mal lineages, including fat, muscle, bone and cartilage17e19
when provided the proper soluble and environmental cues.
These cells are expandable in culture20, and therefore may
be grown in sufﬁcient numbers to populate engineered scaf-
folds, serving as an alternative source for fully differentiated
chondrocytes.
In general, chondrogenic differentiation of MSCs has
been effected by the application of growth factors from the
transforming growth factor-b (TGF-b) superfamily21e25, in
the presence of ascorbate and dexamethasone. Original
studies of MSC chondrogenesis were carried out to mimic
cartilage development in the embryonic limb bud, i.e., in
high cell density micromass or pellet culture21,26, to promote
cellular condensation. Translating these studies to the
realm of tissue engineering, a number of recent studies
have shown that MSCs can differentiate in scaffolds such
as ﬁbrin27, agarose28,29, hyaluranon/gelatin28, alginate hy-
drogels25,28,30,31, photopolymerizing hydrogels32, as well9
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geleﬁber amalgams35.
In the majority of these studies, chondrogenic differentia-
tion has been characterized by the emergence of cartilage-
speciﬁc markers, such as the expression and deposition of
collagen type II, aggrecan, and sulfated proteoglycans.
While many studies show that MSCs undergo chondrogen-
esis, few have assayed the efﬁciency of their chondrogenic
activity or their ability to produce functional material proper-
ties within the scaffold. For tissue engineering of cartilage,
MSCs must not only differentiate in the three-dimensional
(3D) context but also produce constructs with mechanical
properties similar to those achieved with differentiated
chondrocytes36e38. Preliminary reports on the mechanical
properties of adipose derived MSC-laden hydrogels sug-
gest that while undergoing differentiation, the constructs
do not acquire signiﬁcant material properties over a 4-
week culture period28. This failure to achieve signiﬁcant
stiffness over this time course raises a serious practical
concern for growing functional tissue replacements.
To address these issues, the goals of this study were to
ﬁrst determine if the bovine model system, using animals
derived from a slaughterhouse, would yield a sufﬁcient sup-
ply of marrow derived multipotential MSCs. While numerous
studies have been carried out with bovine chondrocytes,
few have reported on MSCs from this animal source39,40.
After identifying a multipotential population, the second
goal of this study was to compare the development of me-
chanical properties in constructs seeded with chondrocytes
and MSCs from the same animals seeded in an agarose hy-
drogel culture system. Given the well-documented sensitiv-
ity of mature chondrocytes to modulators of chondrogenesis
(particularly those from the TGF-b superfamily)41e47, we ex-
amined the response of both MSC- and chondrocyte-laden
agarose hydrogels in a basal (BM) and TGF-b-containing
chondrogenic medium (CM) over 10 weeks of free swelling
culture. We hypothesized that after an initial delay, during
which MSCs commit to the chondrogenic lineage, the efﬁ-
ciency of cartilage matrix production and accumulation of
mechanical properties would be similar for both cell types
exposed to the same stimuli.
Materials and methods
CHONDROCYTE AND MARROW STROMAL CELL ISOLATION
AND CULTURE
Bone marrow derived MSCs were harvested from either
the carpal bones or the tibia and femur of freshly slaugh-
tered (!36 h) 3e6 month old calves (Fresh Farms Beef,
Rutland, VT). Typically, six separate carpal bone marrow
isolations (minimum of three animals) or four separate fe-
mur/tibia marrow isolations (minimum of four animals)
were carried out simultaneously. The marrow was then re-
moved and deposited into an equal volume of Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM) supplemented with 1!
penicillin/streptomycin/fungizone (PSF) with an additional
300 U/mL heparin. After vortexing for 5 min, marrow sam-
ples were separated from fat (by centrifugation for 5 min
at 300! g) and the resulting solution was plated onto
a 15 cm tissue culture plate (Falcon Becton Dickinson Lab-
ware, Franklin Lakes, NJ). After an initial period of 48 h
to allow for cell attachment, cultures were washed with
phosphate buffered saline (PBS) and then maintained in
Expansion Medium (EM) (described in Assays for Multipo-
tentiality), with medium changed twice weekly, until cultures
reached conﬂuence. Subsequent sub-culturing was carriedout at a 1:3 expansion ratio, with cultures up to passage
four utilized for these studies. For initial differentiation stud-
ies, individual donor samples were maintained separately;
for long-term agarose culture studies, MSCs from all donors
were combined after culture expansion but prior to
encapsulation.
Articular cartilage was harvested from the carpometacar-
pal joints of the same group of animals. Cartilage was re-
moved from the joint, rinsed in DMEM containing 2!
PSF, and incubated overnight at 37(C in a humidiﬁed 5%
CO2 incubator. Cartilage pieces were combined and di-
gested sequentially with pronase and collagenase as de-
scribed previously10. The chondrocyte suspension was
ﬁltered (40 mm cell strainer, BD Falcon, Bedford, MA), pel-
leted (5 min, 300! g), resuspended in DMEM, and viable
cells counted. In order to match chondrocytes from the
same isolation with their accompanying MSC population,
chondrocytes were slowly culture expanded through pas-
sage two. Typically, chondrocytes were cultured at
w70,000 cells/cm2 to achieve high initial conﬂuency so as
to limit cell division and maintain the chondrocyte pheno-
type48, with chondrocyte sub-culturing occurring once every
2 weeks. Chondrocytes were maintained in the same EM as
used for the MSCs.
ASSAYS FOR MULTI-LINEAGE DIFFERENTIATION POTENTIAL
Bovine marrow derived MSCs were tested for three differ-
ent differentiation lineages: adipogenesis, osteogenesis,
and chondrogenesis as described previously49. All cell pop-
ulations were expanded individually in EM, consisting of
high glucose (hg) DMEM containing 1! PSF and 10% fetal
bovine serum (FBS).
To test for osteogenesis and adipogenesis, MSCs were
plated in six-well plates (Corning Costar, Inc., Corning, NY)
at 200,000 cells/well and exposed to osteogenic medium
(OS), adipogenic medium (AS), or EM for 21 days. OS con-
sisted of hgDMEM supplemented with 10% FBS, 1! PSF,
10 nM dexamethasone, 10 mM b-glycerophosphate, 50 mg/
mL ascorbate 2-phosphate and 10 nM 1,25-dihydroxyvita-
min D3. AS consisted of hgDMEM supplemented with 10%
FBS, 1! PSF, 1 mM dexamethasone, 1 mg/mL insulin and
0.5 mM 3-isobutyl-1-methylxanthine. Media were changed
twice weekly. Osteogenesis was determined by ﬁxing mono-
layers in isopropanol and staining with Alizarin Red (2%,
Rowley Biochemicals, Danvers, MA) for mineralized matrix.
Adipogenesis was assessed by ﬁxing with paraformalde-
hyde and staining with freshly prepared Oil Red O (Sigma,
0.18% w/v in 60% isopropanol) to visualize lipid droplets.
Chondrogenic potential of the bovine MSC populations
was evaluated using the pellet culture system18,19,21. Cells
were released with 0.25% trypsin, counted, and total RNA
from 1! 106 cells from each animal was extracted using
Trizol reagent (Invitrogen, Carlsbad, CA). Baseline expres-
sion of speciﬁc genes (see below) were assayed by re-
verse-transcriptase polymerase chain reaction (RT-PCR).
To assay for chondrogenic potential of the MSC popula-
tions, pellets containing 250,000 bovine MSCs were formed
in 96-well polypropylene plates (Nalge Nunc International,
Rochester, NY) via centrifugation for 5 min at 300! g. Cul-
tures were maintained in CM consisting of hgDMEM supple-
mented with 1! PSF, 0.1 mM dexamethasone, 50 mg/mL
ascorbate 2-phosphate, 40 mg/mL L-proline, 100 mg/mL so-
dium pyruvate, 1! insulinsetransferrineselenous acidC
with (CMC) and without (CM) TGF-b3 (R&D Systems,
Minneapolis, MN, 10 ng/mL), with medium changed twice
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and 11, and ﬁxed for histology or frozen in 1 mL Trizol re-
agent. After parafﬁn embedding and sectioning, pellets
were stained with Safranin O (for proteoglycans) and Picro-
sirius Red (for collagens). For RT-PCR, total RNA from four
to six pellets per donor was quantiﬁed using a Nanodrop
ND-1000 spectrophotometer (Nanodrop Technologies,
Rockland, DE). Reverse transcription of 500 ng RNA was
performed using the First Strand cDNA Synthesis kit
(Invitrogen Life Technologies) with oligo(dT) primers. PCR
ampliﬁcation was carried out with primers speciﬁc for aggre-
can, cartilage oligomeric matrix protein (COMP), collagen
types I, II, and IX, and the housekeeping gene glyceralde-
hyde-3-phosphate dehydrogenase, as described previous-
ly34. PCR products were resolved on a 2% agarose gel,
visualized with ethidium bromide.
LONG-TERM AGAROSE CULTURE
For long-term agarose culture, three separate prepara-
tions of MSCs and chondrocytes from at least three animals
were used. MSCs were expanded through passage three,
while chondrocytes from the same donors were expanded
through passage two. To produce constructs, a sterile aga-
rose solution (42(C, 4% w/v in PBS, type VII, Sigma) was
combined 1:1 with MSCs or chondrocytes in DMEM (40 mil-
lion cells/mL), and cast between parallel glass plates, as
described previously10,50. After 20 min gelation at room
temperature, cylindrical samples were cored using a dermal
punch (B 5 mm, Miltex, York, PA). Constructs (25e30/dish)
laden with MSCs and chondrocytes were cultured in 30 mL
medium (CMC, CM, or BM) that was changed twice
weekly over a 10-week period, with ascorbate, dexametha-
sone, and TGF-b3 added fresh with each change. BM con-
sisted of hgDMEM supplemented with 10% FBS, amino
acids (0.5! essential amino acids, 1! non-essential
amino acids), buffering agents (10 mM 4-(2-hydroxyethyl)-
piperazine-1-ethanesulfonic acid, 10 mM NaHCO3, 10 mM
N-[tris(hydroxymethyl)methyl]-2-aminoethanesulfonic acid,
10 mM N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid),
and 1! PSF with fresh 50 mg/mL ascorbate. At 2-week in-
tervals, three to four samples from each preparation were
removed for mechanical, biochemical, and histological
analyses.
MECHANICAL TESTING
Mechanical testing was performed using a custom appa-
ratus50,51. Sample thickness and diameter were measured
with a digital micrometer. Constructs were tested in uncon-
ﬁned compression between two smooth impermeable surfa-
ces in PBS at room temperature. Samples were ﬁrst tested
in creep under a tare load of 0.02 N applied until equilibrium
was achieved (w300 s). Subsequently, stress relaxation
tests were carried out with a compressive deformation of
1 mm/s to 10%, after which samples were allowed to relax
to equilibrium (1200 s). The equilibrium compressive
Young’s modulus (EY) was determined from the equilibrium
force normalized to the original cross-sectional area divided
by the equilibrium compressive strain. After equilibrium was
achieved, dynamic testing was carried out by applying 1%
oscillatory deformation at 0.1, 0.5, and 1.0 Hz. The dynamic
modulus (ED) for each frequency was calculated from the
slope of the compressive stress as a function of the com-
pressive strain, as in Ref.52. After testing, samples were fro-
zen at 20(C for subsequent biochemical analysis.BIOCHEMICAL ANALYSIS
To determine the biochemical composition of samples at
various time points, assays were performed to determine
the proteoglycan, DNA, and bulk collagen (ortho-hydroxy-
proline (OHP)) content. Samples were ﬁrst weighed wet
and digested for 16 h in papain at 60(C. Aliquots were an-
alyzed for sulfated glycosaminoglycan (sGAG) content us-
ing the 1,9-dimethylmethylene blue dye-binding assay53,
for DNA content using the PicoGreen dsDNA Quantiﬁcation
kit (Molecular Probes, Eugene, OR), and for OHP content
(after acid hydrolysis) by reaction with chloramine T and di-
methylaminobenzaldehyde54. OHP was converted to colla-
gen content using a 1:10 ratio of OHP:collagen55. Each
constituent (DNA, sGAG, OHP) was normalized to the wet
weight (ww). On separate Day 70 samples, collagen type
II content was assessed using a sandwich ELISA kit (Chon-
drex, Inc., Redmond, WA) according the manufacturer’s
recommendations.
HISTOLOGY
Samples for histology were ﬁxed overnight at 4(C in
paraformaldehyde, dehydrated in a graded series of etha-
nol, embedded in parafﬁn (Tissue Prep, Fisher Scientiﬁc),
and sectioned at 8 mm thickness. Sections were stained
with hematoxylin and eosin (H&E, Sigma, St. Louis, MO)
for general histology, with Safranin O (1% aqueous solution,
pH 6.7) or Alcian Blue (pH 1.0) to detect sulfated proteogly-
cans, and with Picrosirius Red (0.1% w/v in saturated picric
acid) to view collagen deposition. Stained specimens were
imaged with a color charge coupled device camera and an
inverted microscope. To assess cell viability on Day 77,
chondrocyte- and MSC-laden constructs were stained using
the LIVE/DEAD cell viability kit (Molecular Probes, Eugene,
OR) according to the manufacturer’s protocol, and imaged
in cross-section using a ﬂuorescent microscope.
STATISTICAL ANALYSIS
All data are reported as the mean and standard deviation
of three to nine samples (depending on the group, measure,
and time point). Analysis of variance was performed using
the STATISTICA software package (Statsoft, Tulsa, OK)
with cell source (chondrocyte or MSC), media (BM, CM,
or CMC) and time in culture (0, 14, 28, 42, 56, and 70
days) as independent variables and thickness, diameter,
wet weight, Young’s and dynamic moduli, sGAG/ww, DNA/
ww, and Collagen/ww as dependent variables. Post hoc
comparisons were made using the Tukey’s honest signiﬁ-
cant difference test for unequal sample sizes, with aZ 0.05.
Results
CHARACTERIZATION OF THE MULTIPOTENTIALITY OF BOVINE
MESENCHYMAL CELLS
MSCs and chondrocytes isolated from bovine bone mar-
row and articular cartilage exhibited distinct cellular mor-
phologies in monolayer culture. Analysis of gene
expression showed a consistent expression of cartilage
marker genes (aggrecan and COMP) in chondrocytes, indi-
cating a retention of phenotype during expansion, whereas
MSCs from six donors failed to express these genes (data
not shown). When these MSCs were cultured in the pres-
ence of either adipogenic or OS for 21 days, each popula-
tion deposited fat droplets [Fig. 1(B)] or mineralized matrix
182 R. L. Mauck et al.: Chondrogenesis of MSCs in 3D cultureFig. 1. Bovine MSCs undergo both adipogenesis and osteogenesis in conﬂuent monolayer cultures after 21 days of exposure to adipogenic
(B) or osteogenic (D) medium compared to those cultured in BM (A and C). (A and B) Oil Red O staining; (C and D) Alizarin Red staining.
Scale bar: 50 mm (A and B) or 200 mm (C and D).[Fig. 1(D)], respectively. When cultured as pellets in CM
supplemented with 10 ng/mL TGF-b3, MSCs showed in-
creased pellet size and time-dependent induction of aggre-
can, COMP, and collagen types II and IX expression
(Fig. 2). These results indicate that bovine marrow derived
mesenchymal cells possess a multi-lineage differentiation
potential, including adipogenesis, osteogenesis, and
chondrogenesis.
LONG-TERM CULTURE OF CELL-LADEN AGAROSE
CONSTRUCTS
Cell morphology, viability, and physical parameters
in 3D culture
To examine the long-term properties of MSCs and chon-
drocytes in 3D culture, each cell type was encapsulated in
agarose at 20 million cells/mL. Both cell types survived
the encapsulation process and took on a spherical morphol-
ogy, with MSCs appearing larger than chondrocytes
(Fig. 3). The physical parameters of constructs (thickness,
diameter, and wet weight) were dependent on time in cul-
ture (P! 0.001), cell type (MSC or chondrocyte,
P! 0.001), and medium conditions (BM, CM, or CMC,
P! 0.001). In particular, chondrocyte- and MSC-laden con-
structs showed signiﬁcant increases in thickness (w33%and w19%, P! 0.01 vs Day 0) and diameter (w22%,
P! 0.01 vs Day 0 and 4%, not signiﬁcant) in CMC (data
not shown), with Day 70 chondrocyte seeded constructs
in CMC signiﬁcantly larger and heavier than MSC-laden
constructs similarly maintained (P! 0.02).
Extracellular matrix distribution and content
in 3D culture
In addition to changes in physical parameters, there were
clear changes in the amount and distribution of the forming
extracellular matrix (ECM) depending on cell type and cul-
ture condition. Staining of chondrocyte-laden constructs
with Alcian Blue for sulfated proteoglycan revealed a steady
accretion of positive staining with all culture conditions
(Fig. 4). For MSC-laden constructs, little to no staining
was observed in BM medium, while some spontaneous dif-
ferentiation was observed in CM. When cultured in CMC,
MSC-laden gels showed positive staining of a similar inten-
sity to that achieved in chondrocyte-laden constructs simi-
larly maintained.
Quantifying the biochemical constituents in these con-
structs also revealed differences that were dependent on
time in culture (P! 0.001), cell type (MSC or chondrocyte,
P! 0.001), and medium condition (BM, CM, or CMC,
P! 0.001).
183Osteoarthritis and Cartilage Vol. 14, No. 2Fig. 2. Analysis of cartilage phenotype in bovine chondrocyte and MSC cultures. (A) Chondrogenic gene expression in bovine chondrocytes
(CH) or MSCs in monolayer (mono) culture and MSCs in pellet culture in CM with (C) or without () 10 ng/mL TGF-b3. MSCs in pellet culture
show a time-dependent increase in cartilage-speciﬁc matrix gene expression in the presence of TGF-b3. (B) Sections of Day 11 MSC pellets
cultured in CM. a, b: Safranin O staining; c, d: Picrosirius Red staining. a, c: CM; b, d: CMC; scale bar: 300 mm.sGAG content (% wet weight) increased in chondrocyte-
laden disks under each medium condition (P! 0.01 vs Day
0, Fig. 5). MSC-laden constructs increased in sGAG content
only when cultured in CMC(P! 0.001 vs Day 0). After 70
days, sGAG content of chondrocyte-laden constructs was
higher than that of all other groups (P! 0.0002).
Collagen content (% wet weight) increased in chondro-
cyte-laden disks under each medium condition (P! 0.01
vs Day 0, Fig. 5). MSC-laden constructs increased in colla-
gen content when cultured in both CMC and CM
(P! 0.001 vs Day 0), but not in BM. After 70 days of culture,
the collagen content of chondrocyte-laden constructs in
CMC was not different from MSC-laden constructs. The
content of collagen type II of these CMC constructs was
not different from one another (CH: 107G 6 mg/construct
vs MSC: 107G 21 mg/construct, nZ 3), although concerns
related to completeness of extraction precluded an exact
comparison.
DNA content (normalized to wet weight) increased in
chondrocyte-laden disks in CMC by Day 42 (P! 0.01,
Fig. 5) and then fell to levels not different than starting levels
on Day 70. These ﬂuctuations represent a marked change
in DNA amount, which was partially countermanded by
the concomitant increases in wet weight. MSC-laden con-
structs displayed only marginal increases in DNA content.
After 70 days in CMC, DNA content (per wet weight) of
chondrocyte-laden constructs was wtwo-fold higher than
that of MSC-laden constructs (wthree-fold difference in total
DNA content per construct). Viability staining revealed that
chondrocytes survived in each media with proliferation in
CMC, while MSCs survived only in CM and CMC (Fig. 4).
Mechanical properties of constructs in 3D culture
The equilibrium and dynamic mechanical properties of
constructs were dependent on time in culture (P! 0.001),
cell type (MSC or chondrocyte, P! 0.001), and medium
condition (BM, CM, or CMC, P! 0.001). The equilibriumYoung’s modulus of chondrocyte-laden constructs in-
creased in CMC, reaching 140G 18 kPa by Day 70
(P! 0.0001 vs Day 0, Fig. 6). Chondrocyte-laden con-
structs in CM and BM were signiﬁcantly softer
(P! 0.0001), reaching 23G 4 kPa and 16G 4 kPa by
Day 70, respectively. MSC-laden constructs in CMC also
increased in stiffness, reaching 48G 12 kPa by Day 70
(P! 0.01 vs Day 0, Fig. 6). MSC-laden constructs in
CM and BM were signiﬁcantly softer (P! 0.0001), reach-
ing 6G 1 kPa and 4G 2 kPa by Day 70, respectively. After
70 days in CMC, chondrocyte-laden constructs were signif-
icantly stiffer than MSC-laden constructs maintained simi-
larly (P! 0.0001). The dynamic modulus (measured at
1 Hz) of these constructs showed a similar pattern
(Fig. 6). By Day 70, chondrocyte-laden constructs in
CMC achieved a dynamic modulus of 1.4G 0.2 MPa while
MSC-laden constructs achieved a lower value of
0.8G 0.1 MPa (P! 0.0001).
Rate of production of biochemical constituents
and mechanical properties
When the rate of change of these biochemical and me-
chanical parameters was considered (Table I), differences
were observed between groups. In general, the maximum
rate of change in measured parameters was more robust
and/or occurred at earlier time points for chondrocyte-laden
disks cultured in CMC than for those cultured under any
other condition. For example, while a similar maximal rate
of production of collagen and sGAG in chondrocyte- and
MSC-laden CMC disks was observed, these maxima oc-
curred at later time points for the MSC-laden disks. For
sGAG content, although these constructs reached a similar
maximum rate of production, similar levels of sGAG content
were not achieved. This ﬁnding indicates that while pos-
sessed of the capacity for quickly generating cartilaginous
matrix, MSCs were unable to do so over the entire time
course of the study.
184 R. L. Mauck et al.: Chondrogenesis of MSCs in 3D cultureFig. 3. Primary high-density culture of bovine chondrocytes (top left) and expansion of bovine bone marrow derived MSCs (top right) demon-
strating differences in cellular morphology. Scale bar: 100 mm. Bovine chondrocytes and MSCs in 3D agarose culture take on a rounded mor-
phology and remain viable after encapsulation. Bright-ﬁeld (middle) and LIVE/DEAD (bottom) images of bovine chondrocytes (left) and MSCs
(right) 24 h after encapsulation at a concentration of 20 million cells/mL. Scale bar: 50 mm (middle) or 100 mm (bottom).Discussion
The developmental history of the chondrocyte results in
a cell whose biosynthetic activities are optimized to main-
tain the concentration and structural organization of the car-
tilaginous matrix. This specialization of cellular activity,
which is tuned to the mechanical loading environment, en-
sures the formation of a mature tissue whose ECM can
function in a mechanically demanding in vivo environment.
To engineer this unique tissue, numerous studies (using
fully differentiated chondrocytes) have monitored the gener-
ation of these functional cartilaginous properties with
changes in experimental inputs, such as modulations of
the mechanical loading environment in vitro10,14,50,56e58.
As a ﬁrst step in extending these studies to incorporate mul-
tipotential MSCs in place of chondrocytes, this study directly
tested the matrix forming capacity of bovine MSCscompared to that of chondrocytes isolated from the same
group of animals in long-term free swelling agarose culture.
We posited that MSCs would undergo chondrogenesis in
agarose, but would require additional time to begin produc-
ing high levels of functional ECM to match the activity of
fully differentiated chondrocytes.
This study ﬁrst demonstrated the possibility of the isola-
tion of a pool of adherent multipotential MSCs in bovine
bone marrow that could be induced to differentiate along
adipogenic, osteogenic, and chondrogenic lineages, using
standard assay techniques49. In these studies, we further
demonstrated positive chondrogenesis with accompanying
increases in mechanical properties for these bovine MSCs
seeded in agarose hydrogels at 20 million cells/mL over
a 10-week time course. This positive chondrogenesis con-
ﬁrms previous reports of chondrogenesis in agarose using
both human and rabbit marrow derived MSCs29,59, as well
185Osteoarthritis and Cartilage Vol. 14, No. 2Fig. 4. Alcian Blue staining of Day 70 constructs reveals the formation of a proteoglycan-rich cartilaginous matrix in both chondrocyte- (ﬁrst
column) and MSC- (third column) laden constructs with differing medium compositions. Scale bar: 100 mm. Cell viability of constructs analyzed
by LIVE/DEAD staining of chondrocyte- (second column) and MSC- (fourth column) laden constructs after 11 weeks of culture with differing
medium compositions. Chondrocytes are viable in every culture condition, with evidence of cell division in CMC. Bovine MSCs remain viable
in 3D culture only when cultured in CM. Scale bar: 100 mm.as human adipose derived adult stem (ADAS) cells28. Inter-
estingly, in this latter study, ADAS cells seeded in agarose
at 10 million cells/mL failed to accumulate mechanical prop-
erties over a 28-day time period28, countering the ﬁndings of
the current study using a seeding density of 20 million cells/
mL. This discrepancy suggests a difference in functional
chondrogenic potential depending on the origin (marrow
vs adipose tissue) and/or age of the stem cell source60,
as well as a possible dependence on seeding density, as
has been observed for chondrocytes seeded in both hydro-
gels and ﬁbrous matrices8,10,61,62.
To prove the clinical potential to form cartilaginous con-
struct using multipotential MSCs, direct comparisons of
the matrix forming potential of these cells to differentiated
chondrocytes must be undertaken. In this study, due to
the possibility that components of the CM might enhance
the growth of chondrocytes in agarose, both chondrocytes
and MSC-laden gels were cultured in both BM and CM,
with (CMC) and without (CM) the addition of TGF-b3.
The marked growth of chondrocyte-laden gels in CMC pro-
vides a positive control for MSC-laden gels, and indicates
(when compared to CM medium) that TGF-b3 has a pro-
found effect on chondrocyte-laden construct growth. In-
deed, the mechanical properties of chondrocyte-laden
disks in this medium (CMC) far surpassed those of disks
maintained in BM in this and previous studies61. This ﬁnding
indicates that a chemically deﬁned serum-free medium can
be successfully employed for cartilage tissue engineering
studies, as has been suggested in studies examining chon-
drocytes seeded in self-assembling peptide hydrogels63,
particularly when combined with positive modulators of ma-
trix biosynthesis.
Bovine MSCs cultured under the same chondrogenic
conditions (CMC) showed signiﬁcant accumulations of
cartilaginous matrix, although the mechanical properties
achieved in these gels were two- to three-fold lower thanthat produced by chondrocytes cultured under the same
conditions. This ﬁnding suggests a limited matrix forming
capacity of MSCs in this 3D culture. These ﬁndings are con-
sistent with the recent ﬁndings of reduced MSC potential in
studies in alginate hydrogels64 using a mixed bovine chon-
drocyte/equine model system. These results suggest for the
ﬁrst time that there may exist an inherently reduced efﬁcacy
in matrix forming potential in MSCs that have undergone
chondrogenic differentiation that is independent of the hy-
drogel employed, which must be overcome to optimize their
clinical applicability.
When initiating these studies, we hypothesized that a de-
lay (during which chondrogenesis and commitment to phe-
notype proceeds) would be apparent for MSC-laden gels
that would slow their maturation compared to chondro-
cyte-laden gels similarly maintained. To address this possi-
bility, we explored the maximum rate of change of the
measured parameters over the 10-week time course. This
analysis indicated that over the entire time course, nearly
every metric had a higher rate of change for chondrocyte-
laden gels compared to MSC-laden gels. When similar in
magnitude, these maxima occurred earlier for chondro-
cyte-laden gels compared to MSC-laden gels. Moreover,
several important parameters, such as the sGAG content
and equilibrium and dynamic moduli, appear to have
reached a plateau in MSC-laden gels, but continue to in-
crease in chondrocyte-laden gels similarly maintained.
The one noted exception was collagen content, which
was not different between chondrocyte- and MSC-laden
gels in CMC medium on Day 70. Preliminary characteriza-
tion of collagen type revealed a similar amount of collagen
type II in gels seeded with both cell types. Conversely, the
marked increase in DNA content observed in chondrocyte-
laden constructs in CMC resulted in a three-fold increase in
cell number over MSCs over the 10-week time course. This
ﬁnding is consistent with staining for cell viability, with
186 R. L. Mauck et al.: Chondrogenesis of MSCs in 3D cultureobvious chondrocyte division in CMC medium. Thus, one
explanation for the enhanced growth of chondrocyte-laden
gels compared to MSC-laden gels may be the accumula-
tion of cells via proliferation. Recent studies exploring
MSC-laden gels seeded at three times the seeding density
Fig. 5. sGAG content (%ww), bulk collagen content (%ww), and
DNA content (DNA*1000 (per ww)) of chondrocyte- and MSC-laden
constructs in free swelling culture in different media over a 10-week
time course. In CMC, chondrocyte-laden constructs show larger in-
creases in sGAG and DNA content than MSC-laden constructs,
while similar bulk collagen levels are achieved in each cell type.
CMC: CM with TGF-b3; CM: CM without TGF-b3. Data represent
the mean and standard deviation of three to nine samples per
group. *Indicates P! 0.05 vs Day 0 within group; **indicates
P! 0.05 between groups on Day 70.used in this study (60 million cells/mL), however, suggest
that even with DNA content similar to the ﬁnal levels
observed in chondrocyte-laden gels in this study, MSC-
laden gels are not able to produce a similarly functional ma-
trix65. These ﬁndings suggest that even under balanced
conditions of cell density and medium equivalency, chon-
drocytes out-perform MSCs in forming a functional matrix.
The ﬁndings of this study bring forth a number of interest-
ing ideas regarding the application of chondrogenically dif-
ferentiated MSCs for tissue engineering applications. With
the caveat that this is a single study, in one animal system,
Fig. 6. Equilibrium compressive Young’s modulus (EY) and dy-
namic modulus (ED, 1 Hz) of chondrocyte- and MSC-laden con-
structs in free swelling culture in different media over a 10-week
time course. Increases in mechanical properties are most promi-
nent in cultures maintained in CMC, with chondrocyte-laden con-
structs achieving a higher stiffness than MSC-laden constructs
similarly maintained. CMC: CM with TGF-b3; CM: CM without
TGF-b3. Data represent the mean and standard deviation of three
to nine samples per group. *Indicates P! 0.05 vs Day 0 within
group; **indicates P! 0.05 between groups on Day 70.Table I
Maximal rate of change in construct parameters for chondrocytes and MSCs over a 10-week culture period*
Group Chondrocytes MSCs
CMC CM BM CMC CM BM
Thickness (mm/week) 0.10 (28e42) 0.10 (28e42) 0.05 (42e56) 0.13 (56e70) 0.04 (14e28) 0.03 (42e56)
Diameter (mm/week) 0.17 (58e70) 0.06 (14e28) 0.04 (14e28) 0.03 (28e42) 0.03 (14e28) 0.06 (14e28)
Wet weight (mg/week) 6.7 (58e70) 5.3 (0e14) 8.0 (28e42) 4.8 (56e70) 4.8 (28e42) 2.0 (0e14)
GAG (%ww/week) 0.688 (0e14) 0.582 (0e14) 0.219 (28e42) 0.571 (14e28) 0.197 (14e28) 0.005 (0e14)
DNA*1000 (per ww/week) 0.228 (28e42) 0.014 (14e28) 0.109 (0e14) 0.062 (0e14) 0.058 (14e28) 0.027 (14e28)
Collagen (%ww/week) 0.40 (0e14) 0.09 (0e14) 0.14 (42e58) 0.37 (14e28) 0.18 (14e28) 0.01 (0e14)
EY (kPa/week) 40.10 (14e28) 5.74 (14e28) 3.48 (28e42) 17.06 (14e28) 2.72 (14e28) 1.94 (14e28)
ED (kPa/week) 283.3 (58e70) 51.7 (28e42) 19.4 (28e42) 201.2 (28e42) 19.9 (28e42) 1.9 (28e42)
Alcian Blue (Day 70) CCC CC CCC CCC  
Viability (Day 77) CCC CC CC CC CC 
*Number in parentheses indicates time period (days) over which maximal change occurred.
187Osteoarthritis and Cartilage Vol. 14, No. 2based on an in vitro culture system, our ﬁndings show for
the ﬁrst time that MSCs, compared to fully differentiated
chondrocytes, have a reduced potential in terms of func-
tional matrix forming capacity. To minimize variability and
possible age-related decreases in potential, this study
used MSCs and chondrocytes taken from the same group
of young healthy calves, a best-case scenario. Upon further
consideration, it should perhaps be expected that even un-
der these optimal conditions MSCs would under-perform
chondrocytes; the chondrocyte has a developmental history
which shapes its phenotype, while the MSC is being pushed
towards a particular lineage using a combination of growth-
factors concocted in an in vitro setting. Our results
suggest that successful tissue engineering of cartilaginous
constructs using MSCs will require the optimization of the
differentiation conditions. Furthermore, engineering consid-
erations of the properties that are necessary and sufﬁcient
for in vivo function must take into account the maximal
rate of synthesis of newly differentiated cells, and charac-
terize the degree to which they continue maturing once
implanted in vivo.
Conclusions
While MSCs have been shown to undergo chondrogenic
differentiation, few studies have assessed the mechanical
integrity of the matrix formed by these newly differentiated
cells. Furthermore, the efﬁcacy of these cells in forming
a functional matrix must be compared directly to that of
healthy chondrocytes from the same donor for a proper
comparison to be made. This necessitates the utilization
of animal models that provide a sufﬁcient supply of healthy
cells of both types, not typically available in human sam-
ples. The results of this study show that while chondrogenic
differentiation does occur in MSC-laden hydrogels, the
amount of the forming matrix and measures of its mechan-
ical properties are lower than that produced by chondro-
cytes from the same group of donors. Furthermore, the
fact that sGAG content and mechanical properties plateau
in MSC-laden constructs suggests that the results are not
simply due to a delay while differentiation occurs. These
results suggest that while MSC-laden constructs can devel-
op mechanical cartilaginous properties, further optimization
must be done to achieve levels similar to those produced by
differentiated chondrocytes.
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